JP2015505541A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505541A5 JP2015505541A5 JP2014553622A JP2014553622A JP2015505541A5 JP 2015505541 A5 JP2015505541 A5 JP 2015505541A5 JP 2014553622 A JP2014553622 A JP 2014553622A JP 2014553622 A JP2014553622 A JP 2014553622A JP 2015505541 A5 JP2015505541 A5 JP 2015505541A5
- Authority
- JP
- Japan
- Prior art keywords
- nasal
- carrier material
- powder
- inhaled
- nose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012876 carrier material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12000558.2 | 2012-01-28 | ||
| EP12000558 | 2012-01-28 | ||
| PCT/EP2012/005358 WO2013110309A1 (en) | 2012-01-28 | 2012-12-21 | Triazolo[4,5-d]pyrimidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505541A JP2015505541A (ja) | 2015-02-23 |
| JP2015505541A5 true JP2015505541A5 (enExample) | 2016-12-15 |
| JP6063482B2 JP6063482B2 (ja) | 2017-01-18 |
Family
ID=47561514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014553622A Expired - Fee Related JP6063482B2 (ja) | 2012-01-28 | 2012-12-21 | トリアゾロ［４，５−ｄ］ピリミジン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9409914B2 (enExample) |
| EP (1) | EP2807161B1 (enExample) |
| JP (1) | JP6063482B2 (enExample) |
| KR (1) | KR20140117636A (enExample) |
| CN (1) | CN104066734B (enExample) |
| AR (1) | AR089810A1 (enExample) |
| AU (1) | AU2012367141B2 (enExample) |
| BR (1) | BR112014016884A2 (enExample) |
| CA (1) | CA2862694C (enExample) |
| ES (1) | ES2655264T3 (enExample) |
| IL (1) | IL233808B (enExample) |
| MX (1) | MX2014008864A (enExample) |
| SG (1) | SG11201404234YA (enExample) |
| WO (1) | WO2013110309A1 (enExample) |
| ZA (1) | ZA201406323B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2911259A1 (en) * | 2013-05-06 | 2014-11-13 | Merck Patent Gmbh | Macrocycles as kinase inhibitors |
| US20160222014A1 (en) * | 2013-09-10 | 2016-08-04 | Asana Biosciences, Llc | Compounds for regulating fak and/or src pathways |
| CN111440189B (zh) * | 2015-04-24 | 2022-08-09 | 广州再极医药科技有限公司 | 稠环嘧啶氨基衍生物、其制备方法、中间体、药物组合物及应用 |
| MA45940B1 (fr) | 2016-08-10 | 2024-12-31 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique |
| EP3842442B1 (en) | 2016-12-22 | 2023-11-01 | Precision Pharmaceuticals, Inc. | Compositions and methods for inhibiting arginase activity |
| KR102328423B1 (ko) * | 2018-09-11 | 2021-11-18 | 재단법인 대구경북첨단의료산업진흥재단 | 신규 트리아졸로-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물 |
| WO2020070053A1 (en) * | 2018-10-01 | 2020-04-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of inhibitors of stress granule formation for targeting the regulation of immune responses |
| WO2021222147A1 (en) * | 2020-04-27 | 2021-11-04 | Hibercell, Inc. | Heterocyclic gcn2 modulators |
| GB202008749D0 (en) | 2020-06-09 | 2020-07-22 | Ip2Ipo Innovations Ltd | Novel compounds |
| KR20250122240A (ko) | 2024-02-06 | 2025-08-13 | 한미약품 주식회사 | 신규한 함질소 헤테로고리 유도체 및 이의 용도 |
| WO2025179188A1 (en) * | 2024-02-22 | 2025-08-28 | Juno Therapeutics, Inc. | Pyrazole-based inhibitors of dna-dependent protein kinase and compositions and applications in gene editing |
| CN120504636B (zh) * | 2025-07-22 | 2025-10-31 | 江西中医药大学 | 一种磺胺噻唑-甲氧苄啶药物晶盐及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
| BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
| ATE370142T1 (de) | 2003-07-16 | 2007-09-15 | Janssen Pharmaceutica Nv | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 |
| WO2006020145A2 (en) | 2004-07-19 | 2006-02-23 | The Johns Hopkins University | Flt3 inhibitors for immune suppression |
| DE102004051827A1 (de) | 2004-10-25 | 2006-05-04 | Hörmann KG Antriebstechnik | Armbandsender |
| US8153640B2 (en) * | 2004-10-29 | 2012-04-10 | Tibotec Pharmaceuticals Ltd. | HIV inhibiting bicyclic pyrimdine derivatives |
| CA2592457A1 (en) | 2005-01-14 | 2006-07-20 | Janssen Pharmaceutica N.V. | Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| WO2006091737A1 (en) * | 2005-02-24 | 2006-08-31 | Kemia, Inc. | Modulators of gsk-3 activity |
| NZ598907A (en) | 2009-10-20 | 2014-03-28 | Cellzome Ltd | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
-
2012
- 2012-12-21 WO PCT/EP2012/005358 patent/WO2013110309A1/en not_active Ceased
- 2012-12-21 MX MX2014008864A patent/MX2014008864A/es unknown
- 2012-12-21 KR KR1020147023872A patent/KR20140117636A/ko not_active Withdrawn
- 2012-12-21 JP JP2014553622A patent/JP6063482B2/ja not_active Expired - Fee Related
- 2012-12-21 ES ES12816002.5T patent/ES2655264T3/es active Active
- 2012-12-21 SG SG11201404234YA patent/SG11201404234YA/en unknown
- 2012-12-21 EP EP12816002.5A patent/EP2807161B1/en active Active
- 2012-12-21 AU AU2012367141A patent/AU2012367141B2/en not_active Ceased
- 2012-12-21 BR BR112014016884A patent/BR112014016884A2/pt not_active IP Right Cessation
- 2012-12-21 CN CN201280068233.4A patent/CN104066734B/zh not_active Expired - Fee Related
- 2012-12-21 CA CA2862694A patent/CA2862694C/en active Active
- 2012-12-21 US US14/375,067 patent/US9409914B2/en not_active Expired - Fee Related
-
2013
- 2013-01-25 AR ARP130100230A patent/AR089810A1/es unknown
-
2014
- 2014-07-24 IL IL233808A patent/IL233808B/en active IP Right Grant
- 2014-08-27 ZA ZA2014/06323A patent/ZA201406323B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014526447A5 (enExample) | ||
| JP2013544781A5 (enExample) | ||
| JP2014509313A5 (enExample) | ||
| JP2013534227A5 (enExample) | ||
| JP2013541565A5 (enExample) | ||
| Weber et al. | Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art | |
| Yang et al. | Pulmonary drug delivery by powder aerosols | |
| BR122021002471B8 (pt) | Dispositivo de distribuição de droga nasal | |
| EA201590286A1 (ru) | Аэрозольное ингаляционное устройство | |
| WO2014074797A8 (en) | Ultra low density pulmonary powders | |
| IN2014DN09377A (enExample) | ||
| TN2015000395A1 (en) | Respirable agglomerates of porous carrier particles and micronized drug | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| JP2007106777A5 (enExample) | ||
| CL2013000958A1 (es) | Dispositivo atomizador nasal para la administracion de una formulacion farmaceutica a traves de la cavidad nasal en dosis controladas, comprende: un cartucho de aerosol presurizado que a su vez incluye un frasco con una formulacion farmaceutica, el accionador comprende una salida de administracion para el penacho de aerosol, donde el orificio de descarga se encuentra dispuesto de manera de dirigir el penacho de aerosol a traves de la salida de administracion; uso. | |
| EA201690541A1 (ru) | Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы | |
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| JP2013538214A5 (enExample) | ||
| WO2013038267A8 (en) | Tamper resistant pharmaceutical formulations | |
| EA201591869A1 (ru) | Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой | |
| EP4233874A3 (en) | Acetylsalicylic acid for reducing the risk of a thromboembolic event | |
| EA201700182A1 (ru) | Состав для повышения стабильности лекарственного препарата, содержащий по меньшей мере один сухой порошок, полученный распылительной сушкой | |
| EA201590734A8 (ru) | Вдыхаемые лекарственные средства | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| HK1215167A1 (zh) | 可吸入药用组合物和含有该药用组合物的吸入器装置 |